A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Codexis, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 38,222 shares of CDXS stock, worth $176,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,222
Previous 35,794 6.78%
Holding current value
$176,203
Previous $110,000 6.36%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.62 - $3.71 $6,361 - $9,007
2,428 Added 6.78%
38,222 $117,000
Q2 2024

Aug 14, 2024

BUY
$2.65 - $3.92 $94,854 - $140,312
35,794 New
35,794 $110,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $302M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.